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Abstract. A  major cytoskeletal polypeptide (Mr 
•46,000;  protein IT) of human intestinal epithelium 
was characterized by biochemical and immunological 
methods.  The polypeptide, which was identified as a 
specific and genuine mRNA product by translation  in 
vitro, reacted,  in immunoblotting after SDS-PAGE, 
only with one of numerous cytokeratin (CK) antisera 
tested but with none of many monoclonal CK antibod- 
ies. In vitro, it formed heterotypic complexes with the 
type II CK 8, as shown by blot binding assays and gel 
electrophoresis in 4  M  urea,  and these complexes as- 
sembled into intermediate filaments (IFs) under appro- 
priate conditions.  A  chymotrypsin-resistant Mr 
~38,000 core fragment of protein IT could be ob- 
tained from cytoskeletal IFs, indicating its inclusion in 
a coiled coil.  Antibodies raised against protein IT 
decorated .typical  CK fibril arrays in normal and trans- 
formed intestinal  cells.  Four proteolytic peptide frag- 
ments obtained from purified polypeptide IT exhibited 
significant amino acid sequence homology with corre- 
sponding regions of coils I and II of the rod domain of 
several other type I CKs. Immunocytochemically, the 
protein was specifically detected as a prominent com- 
ponent of intestinal and gastric foveolar epithelium, 
urothelial umbrella cells, and Merkel cells of 
epidermis.  Sparse positive epithelial cells were noted 
in the thymus, bronchus, gall bladder, and prostate 
gland.  The expression of protein IT was generally 
maintained  in primary and metastatic colorectal carci- 
nomas as well as in cell cultures derived therefrom.  A 
corresponding protein was also found in several other 
mammalian  species. We conclude that polypeptide IT 
is an integral IF component which is related,  though 
somewhat distantly, to type I CKs, and,  therefore, we 
propose to add it to the human CK catalogue as 
CK 20. 
I 
N epithelial cells, a major element of the cytoskeleton is 
represented by IFs formed by the cytokeratins (CKs),t 
the largest  and most complex group within  the multi- 
gene family of intermediate-sized  filament (IF) proteins (16, 
17, 21, 24, 28-31, 65, 83-86). Besides the 10 different CKs 
that are typical of hair- and nail-forming cells Ctrichocytes") 
but also occur in certain papillary  appendages of the tongue 
and some thymic reticulum cells (also called "hard ~t-kera- 
tins"; e.g., 9, 41),  19 different CK polypeptides have so far 
been distinguished  in  human  epithelial  cells that  are ex- 
pressed in different combinations in the various pathways of 
epithelial  differentiation  during  development and in epithe- 
lial tumors (24, 31, 65, 66, 74, 83-86). These epithelial CKs, 
also referred to as "soft keratins", can be generally divided 
into two subfamilies,  the type I and the type II CKs (9,  12, 
29-31, 73-75, 82-86). In mammals,  all type I CKs identified 
so far have turned out to be more acidic than the members 
of the type II subfamily  (21, 24, 65, 82) but this difference 
1. Abbreviations used in this paper: CK, cytokeratin; IF, intermediate-sized 
filament. 
of charge  is obviously not a necessary principle as shown 
from recent analyses  of fish CKs (61). The basic principle 
of CK filament formation seems to be the requirement of two 
chains of each type I and type lICK polypeptides to consti- 
tute the heterotypie tetramer as the predominant,  if not ex- 
clusive building unit, both in vivo and in vitro (2, 9, 12, 25, 
33, 39, 40, 73-75,  83, 85, 91). 
While in stratified epithelia complex sets of CK "pairs" (for 
term see 19, 85) have been found which are typical of certain 
cell types in these tissues (24, 65, 66, 74, 85, 86), mainly 
four CK polypeptides have so far been identified in the vari- 
ous kinds of single-layered ("simple") epithelia,  i.e., the two 
type I CKs 18 and 19 and the two type II polypeptides 7 and 
8 (19-22, 24, 65, 66, 73, 82, 86). Basically, CK expression 
in simple epithelial cells can be reduced to three major pat- 
terns: 8:18; 8:18, 19; 7, 8:18, 19 (for the rarely occurring pat- 
tern 7, 8:18, see 10, 87).  In the cells of the small  intestine 
and colon of higher vertebrates, one of the most studied tis- 
sues,  the three CKs 8,  18,  and  19 have consistently been 
found (22, 65, 66, 71, 92). In addition,  however, we had con- 
sistently noticed, in our preparations of intestinal cytoskele- 
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of Mr ~46,000 and an isoelectric point (in 9.5 M  urea) of 
pH  ,,,6.1  which we designated "protein IT" because of its 
striking occurrence in intestinal mucosa (36,  63,  65,  67). 
Subsequently, we have found this protein also as a consistent 
component of the IF cytoskeleton of Merkel cell tumors of 
the skin but not in other neuroendocrine tumors (64).  Al- 
though this polypeptide showed some similar biochemical 
properties as the known CKs we could not decide on its pos- 
sible cytokeratinous nature because it did not react with a 
large number of established CK antibodies, nor with anti- 
bodies broadly cross-reacting between diverse IF proteins 
such as that described by Pruss et al. (72), and because we 
were unable  to  formally exclude a  proteolytic derivation 
from CK 8. Therefore, we have characterized this protein in 
greater detail by purification and IF reconstitution, partial 
amino acid sequencing, in vitro translation of mRNAs, and 
with specific antibodies. We now present evidence that pro- 
tein IT represents a hitherto unrecognized type I CK present 
in several kinds of cells of the simple epithelium type. 
Materials and Methods 
Tissues and Cells, and Preparation of  Cytoskeletons 
In most biochemical studies, cytoskeletal preparations of human intestinal 
mucosa were used.  Fresh human duodenum obtained immediately after 
duodeno-pancreatectomy (performed for removal of  pancreatic carcinomas) 
was cut open, rubbed off gently with cellucotton, and mucosal villi were 
scraped off with controlled manual pressure using a spatula. The tissue ma- 
terial thus obtained was immediately frozen in liquid nitrogen and stored 
at  -80°C. In some experiments, specimens from the jejunum, ileum, or 
colon were used, but these contained lesser amounts of protein IT. From 
the scraped tissue material, cytoskeletal preparations were made (1) by 
homogenization with a Polytron homogenizer (Kinematica, Luzern, Swit- 
zerland), and extraction for up to 20 rain with 5 vol of 10 mM Tris-HC1 
buffer (pH 7.2) containing 1.5 M KCI, 0.5% Triton X-100, 5 mM EDTA, 
0.4  mM PMSF,  followed by centrifugation (10  rain,  13,000  g) and two 
washes by resuspension in 5 vol of 10 mM Tris-HCl (pH 7.2) containing 
5 mM EDTA and 0.4 mM PMSF, using a Dounce homogenizer (Kontes 
Glass Co., Vineland, N J), and recentrifugation. All steps were carried out 
on crushed ice or in a cold room of •4°C.  The resulting cytoskeletal pellet 
was stored at  -80°C. 
For comparisons, various other normal and malignant human tissues 
were obtained during surgery or, in a few cases, from autopsies. Pig tissues 
were obtained at a local slaughterhouse, rat and mouse tissues from healthy 
laboratory animals. Tissue samples were immediately frozen in isopentane 
precooled in liquid nitrogen to ~-140°C or directly in liquid nitrogen. Of 
all tissues used, aliquot samples were routinely processed for fixation and 
paraffin embedding,  followed by  pathohistological evaluation.  Further- 
more, the identity of the tissues used was assured by hematoxylin and eosin 
staining of cryostat sections consecutive to those used for the experiments. 
Athymic ("nude") mouse transplantation tumors CX-1, CXF-87 (passage 
10), and CXF-112 derived from human adenocareinomas of the colon (CX-I 
is derived from HT-29 cells; see below) were obtained from the Tumor Bank 
of the German Cancer Research Center (Heidelberg, FRG), excised, and 
immediately frozen in liquid nitrogen (see reference 66). 
The following established colorectal carcinoma-derived  cell culture lines 
from the American Type Culture Collection (ATCC), Rockville, MD, were 
grown essentially as recommended: HT-29 (ATCC HTB 38; see reference 
14); Caco-2 (ATCC  HTB 37;  14); LoVo (ATCC  CCL 229;  11); SW 1116 
(ATCC CCL 233); DLD-1 (ATCC CCL 221); and COLt 320 DM (ATCC 
CCL 220). Cell cultures of the human bladder carcinoma cell line RT-4 (67, 
79) and the human hepatoceUular carcinoma cell line Hep-G2 (13) were 
also used. Cells of the human mammary carcinoma cell line MCF-7 were 
grown as described (see reference 65). In some experiments, cultured cells 
were metabolically labeled with [35S]methionine  (20).  Cytoskeletal frac- 
tions of cultured cells were prepared essentially as described (1). 
Isolation and In Vitro Translation of  RNA 
Total cellular RNA and poly(A)+-RNA were prepared from nude mouse 
transplantation tumors and HT-29 cell cultures and translated in vitro, using 
a reticulocyte lysate system as described (48-50). In some experiments, the 
translation products were immunoprecipitated, using guinea pig antibodies 
against either protein IT or both proteins IT and CK 18 that had been cou- 
pled, at 1:200 dilution, to protein A-Sepharose beads (Pharmacia, Uppsala, 
Sweden), by incubation of the beads with translation assay solution for 1 h 
at room temperature, followed by centrifugation of the beads and several 
washes. Total proteins of the translation assays or proteins immunoprecipi- 
tared therefrom were analyzed by two-dimensional gel electrophoresis and 
autoradiography. 
Gel Electrophoresis 
SDS-PAGE and two-dimensional gel electrophoresis, using either IEF or 
NEPHG electrophoresis were as described (1). Second-dimension SDS- 
PAGE  was usually performed at elevated ionic strength as described by 
Achts~tter et al. (1); in some experiments, the usual low salt buffer system 
was used. 
In some experiments, ~20-/~m-thick cryostat sections of intestinal mu- 
cosa were collected in the frozen state and rapidly immersed into boiling 
SDS-PAGE sample buffer (see also 22). After cooling and centrifugation, 
the proteins present in the supernatant were precipitated by addition of cold 
acetone (9 vol; -20°C), kept at -20"C overnight and, after centrifugation 
and drying, subjected to two-dimensional gel electrophoresis. 
Two-dimensional  gel electrophoresis  under nondissociating  conditions in 
the presence of 4 M urea was carried out as described (73) using tube gels 
(0.3 cm diam; 1 mA per tube) and gel system No. 11, except that 4 M urea 
was used instead of 10 M. Subsequently, the tube gels were subjected to 
second-dimansion  SDS-PAGE using the elevated salt-buffer system. Separa- 
tions of type I and type II CKs with increasing urea concentrations ("melt- 
ing") have been described (25,  39). 
Proteins were visualized by staining with Coomassie brilliant blue R 250 
and,  in labeling experiments, with subsequent processing for fluoroau- 
toradiography using Amplify  TM (Amersham-Buchler, Braunschweig, FRG). 
When the protein loading was low, a silver staining method was used (for 
references  see  1).  Proteins  separated  by  preparative  SDS-PAGE  were 
stained with 4  M  sodium acetate (1). 
Preparation of  Protein IT 
Protein IT was isolated from cytoskeletal material from duodenal mucosa 
by preparative  gel  electrophoresis (SDS-PAGE)  using  the  elevated salt 
buffer system (1). After cutting out the band containing protein IT, protein 
elution, and vacuum dialysis, a second preparative SDS-PAGE with the low 
salt buffer system was performed, and practically pure protein IT was iso- 
lated from the appropriate gel band. 
Alternatively, protein IT was enriched from duodenal cytoskeletal mate- 
rial by chromatographic procedures (1, 39, 40).  Briefly,  the material was 
first subjected to DEAE-cellulose anion exchange chromatography in the 
presence  of  8  M  urea,  using  a  linear  gradient  from  0  to  100  mM 
guanidinium hydrochloride for elution (1). Fractions of the first absorbance 
(280 nm) peak (at '~29 mM guanidinium hydrochloride) contained mainly 
CK 8. The first two peaks (38 and 41 raM) of a broad group of several poorly 
separated peaks contained protein IT but also CK 18 in approximately equal 
amounts. The proportion of protein IT decreased in the last peaks of this 
group.  The last peak (at 53  mM guanidinium hydrochloride) contained 
mainly CK  19.  The combined fractions of the peaks at 38 and 41  mM 
guanidinium hydrochloride were applied directly to reverse-phase HPLC 
using a 4.6  x  250 mm Hi-Pore RP 304 column (BioRad Laboratories, 
Richmond, CA). The proteins were eluted in a acetonitfile gradient (33- 
50%  in 0.1% TFA) (1). After two small peaks containing pure CK 8, the 
main peak eluting at ,x,44% acetonitrile contained almost pure protein IT, 
with occasional trace contaminations of CK 8, its degradation products, or 
CK  18, as recognized by SDS-PAGE and immunoblotting. 
lmmunoblotting and Antibodies 
Immunoblotting of proteins separated by SDS-PAGE or two-dimensional 
gel electrophoresis was as described (1), usually without incubation in the 
4 M urea-containing "protein refolding buffer." 
As primary antibodies, a  series of established monoclonal antibodies 
against CKs were used. For most of these antibodies (CAM 5.2; KG 8.13; 
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19.2.105; KL 1),the CK polypeptide specificities,  references,  and sources 
have been listed in previous articles (10, 15, 36, 41, 47, 59, 67). In addition, 
the following  murine monoclonal antibodies were also applied:  antibody 
AE 1 recognizing several type I CKs (86; kindly provided by Dr. T.-T. Sun, 
New York University,  New York); antibody KA 4 against CKs 14,  15, 16 
and 19 (70; available from Triton Bioscienees Inc., Alameda, CA);  anti- 
body PKK  1 reacting mainly with simple epithelial CKs (43;  from Lab- 
Systems, Helsinki, Finland); antibody DAKO-CK1, corresponding to done 
LP 34, a broad spectrum CK antibody (54; obtained from DAKOPATTS, 
Hamburg, FRG); the CK 18-specific  antibodies CK-1, CK-3 and CK-4 (as 
CK-2; antibodies CK-I and CK-3 were kindly provided by Dr. M. Osborn, 
Max-Planck-Institute for Biophysical Chemistry,  G6ttingen, FRG; CK-4 is 
available from Boehringer Mannheim GmbH, Mannheim, FRG) as well as 
RGE 53 (76). In addition, the CK 19-specific antibodies BA 16 and BA 17 
were used (4; kindly provided by Dr. J. Bartek, Research Institute of Clini- 
cal and Experimental Oncology,  Brno, Czechoslovakia).  In other experi- 
ments, guinea pig antisera raised against bovine muzzle epidermal prekera- 
tins (el. 1% 18, 21, 22, 64), which react with many type I CKs, were used; 
in some experiments, such antisera were affinity purified on nitrocellulose 
paper strips containing CKs 14-17 as described later.  Moreover,  we used 
the monoclonal antibody IFA recognizing  a common antigenic determinant 
of many though not all IF proteins (72; hybridoma cells obtained from 
ATCC;  for reactivity see also 5, 8). 
Immunoreactive bands and spots were  visualized by incubation with 
peroxidase-conjngated  rabbit antibodies against mouse or guinea pig immu- 
noglobulins (DAKOPATTS), which was followed, after washing (see refer- 
ence 1), by staining with a DAB  solution in PBS containing H202  and 
0.015 % nickel-II-sulfate.  Alternatively,  125I-labeled  protein A was used in- 
stead of secondary antibodies,  and the reaction was monitored by autoradi- 
ography (1). Total proteins present on the nitrocellulose filters used for blot 
transfer were stained with Ponceau-S  red (Sigma Chemic, Munich, FRG; 
1) or India ink (37). "Dot blot" assays with monoclonal antibodies,  including 
lu-5 (89), were performed exactly  as described (26). 
Tryptic Peptide  Map Analysis 
For peptide mapping,  individual polypeptides separated by two-dimen- 
sional gel  electrophoresis were  excised,  radiolabeled with  [125I]iodine, 
digested with trypsin and separated by combined electrophoresis and chro- 
matography (for references  see 65, 82). 
Binding Assays and Proteolytic Cleavage  Experiments 
Nitrocellulose blot-binding  assays with radioiodinated purified rat CK poly- 
peptide 8 (A) or human CK 18 were performed essentially as described (40, 
59, 61). 
Proteolytic digestion with chymotrypsin of cytoskeletal material contain- 
ing intact IFs was also performed according to Hatzfeld et al. (40). Typical 
digestion patterns were obtained using enzyme-to-substrate ratios of 6.6- 
9.0:1,000 (wt/wt) and digestion times between 30 and 50 min at room tem- 
perature. 
In Vitro Reconstitution of Heterotypic CK Complexes 
and IFs 
CKs 8, 18, and protein IT purified from duodenal mucosa cytoskeletons  by 
chromatography,  or native cytoskeletal  material from duodenal mucosa, 
were dissolved in a  10 mM Tris-HC1 buffer (pH 8.0) containing 2.5 mM 
DTT and 9.5 M urea. Insoluble material was pelleted at 13,000 g, and the 
supernatants were dialyzed at room temperature, either alone or in near- 
stoichiometric mixtures,  against the same buffer but containing only 4 M 
urea. Aliquots of the resulting solution were cleared by brief  low speed cen- 
trifugation and the supernatant processed for electrophoresis under nondis- 
sociating conditions in the presence of 4 M urea (see above). 
For the in vitro reconstitution of CK filaments (see reference 39), purified 
CK 8 and protein IT were dissolved at 1 mg/ml in 10 mM Tris-HCl buffer 
(pH 8.0) containing 9.5 M urea and 2.5 mM DTT and dialyzed,  alone or 
in an ,M:I mixture, against 4 M urea containing 2.5 mM DTT and 10 mM 
Tris-HCl (pH 7.6) for 1 h and then for 2 h against 10 mM Tris-HCi (pH 
7.6), 2.5 mM DTT ("floating membrane filters"; VS 0.025; Millipore Con- 
tinental Water  Systems,  Bedford, MA). The resulting material was sub- 
jected to negative staining and examined by electron microscopy  (39, 73). 
Amino Acid Sequence  Analysis 
Cytoskeletal proteins from duodenal mucosa were separated by SDS-PAGE 
using the precautions described by Walsh et al.  (90). The proteins were 
stained for 30 rain in 0.5% Coomassie brilliant blue R 250 in H20 under 
gentle shaking, then destained in 1"I20. The protein bands were excised and 
stored at -20"C in a buffer containing 50 mM Tris-acetate (pH 8.5), 0.2% 
SDS,  1 mM DTT,  10% glycerol.  Protein IT was electroeluted  for 20 h in 
an elution device essentially  as described by Hunkapiller et al. (45),  and 
precipitated with cold (-20oc) acetone (9:1 [vol/vol]).  Protein IT (30-40 
#g) was then dissolved in 100 #l of a buffer containing l0 M urea, 100 mM 
Tris-HC1 (pH 8.0),  5 mM DTT,  1 mM EDTA under gentle stirring for 
2-4 h. The 10 M urea solution was diluted with 100 ~1 of buffer containing 
100 mM Tris-HC1 (pH 8.0), and 0.05% NP-40 (Fiuka AG, Buchs, Switzer- 
land). Digestion was started by the addition of 5/~g Staphylococcus aureus 
(VS) protease (ICN Biomedicals,  Inc., Costa Mesa, CA) and carried out 
overnight at room temperature under shaking. For HPLC separation of pep- 
tides, a microbore HPLC system (model 130 A; Applied Biosystems, Foster 
City, CA) was used. The digest was acidified  with 30/~1 of 10% TFA in 
H20,  loaded on a  Vydac Cts column (2.1  x  150 ram; The Separations 
Group, Hesperia, CA). The peptides were eluted at a flowrate of 150 #l/min 
and with the following acetonltrile gradient: buffer A: 0.1% TFA; buffer B: 
80% CHaCN,  0.085% TFA; gradient: 0-25 (20 rain)-25 (10 rain)-35 (15 
min)-35 (10 rain)-45 (10 min)-100% (25 min). Peptide-containing  peaks 
were collected and directly applied to a filter pretreated with BioBrene (Ap- 
plied Biosystems)  and sequenced, using a pnlsediquid protein sequencer 
(model 477A; Applied Biosystems) with an on-line phenylthiohydantoin  an- 
alyzer (model 120A, Applied Biosystems). 
Preparation of Specific Antibodies Against Protein IT 
A guinea pig was immunized with protein IT enriched by preparative gel 
electrophoresis (only one electrophoresis step; see above) essentially as de- 
scribed by Franke et al. (19). The antiserum contained antibodies against 
protein IT as well as some antibodies to CK 18 (64). Antibodies against 
protein IT were isolated from the serum by cross-absorption of either the 
serum (diluted 1:40 in PBS containing 1% BSA and 0.1% sodium azide), 
or the Ig fraction from this serum (obtained by ammonium sulfate precipita- 
tion) using nitrocellulose  strips containing purified CKs 8, 18, and 19 from 
human MCF-7 cells (alternatively, total MCF-7 cytoskeletal  proteins were 
used in some experiments).  Cross-absorption was performed by repeated 
incubations with the nitrocellulose strips that were intermittently regener- 
ated by incubation first in 3 M KSCN (in PBS) and then in PBS. In some 
experiments, the affinity-purification step on nitrocellulose  paper strips con- 
tainlng SDS-PAGE-separated  protein IT (see reference  52) was used and 
here bound antibodies were eluted from the strips with 3 M KSCN (in PBS) 
and vacuum-dialyzed  against PBS. 
Immunocytochemistry 
Methods used for immunofluorescence,  immunopcmxidase and immuno- 
electron microscopy  of cryostat tissue sections and cultured cells were as 
described (3,  16-19, 22, 23, 26, 47, 49, 67). 
Results 
Gel Electrophoresis and Immunoblotting 
Cytoskeletal proteins prepared from human intestinal muco- 
sa consistently revealed, on two-dimensional gel electropho- 
resis (Fig.  1, a and b), the three major CKs 8,  18, and 19, 
together  with a  fourth  major polypeptide  spot previously 
designated IT (65).  With an Mr value of •46,000  and a se- 
ries of isoelectric variants,  this component was positioned 
between CKs 8 and 18 (Fig. 1, a and b). Its major, most basic 
isoclectric variant had an isoelectric pH value (in 9.5 M urea) 
of --6.1 and was slightly more acidic than the nonphosphor- 
ylated variant of CK 8. The next more acidic variant isoelec- 
tric at pH 5.8 was usually present in somewhat lower amounts 
(Fig. 1 a). A further, minor and more acidic variant was de- 
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tinal epithelial cells (a-h,  human; i-l,  rat) after two-dimensional 
gel electrophoresis of cytoskeletal proteins using protein staining 
(a-c, f,  i, and l),  immunoblotting (j and k), in vivo labeling (g), 
and labeling during in vitro translation of mRNA (d, e, and h). IEF 
or NE (NEPHG electrophoresis) indicate the first dimension of 
separation (higher pH values are to the left); vertical arrows denote 
the direction of the second dimension SDS-PAGE, using either the 
elevated (a, b,f, g, i, and j) or the low (c-e, h, k, l) salt buffer sys- 
tem.  Cytokeratins are designated by Arabic numerals (65). The 
thin arrow in a designates an unidentified nonkeratinous compo- 
nent; the arrowhead infa degradation product of CK 8 (see refer- 
ence 81); A, actin; F, vimentin; D, desmin from laminapropria  and 
smooth muscle cells included in some preparations. (a and b) Elec- 
trophoresis of cytoskeletal proteins from human jejunal  (a) and 
duodenal (b) mucosa (Coomassie blue staining), showing promi- 
nent amounts of protein IT. (c and d) Coelectrophoresis of cyto- 
skeletal proteins from CX-1 colon carcinoma (c, Coomassie blue 
staining) and [35S]methionine-labeled  translation products immu- 
noprecipitated after in vitro translation of the corresponding POly- 
A(+)-mRNA (d, fluoroautoradiograph). (e) Similar experiment as 
in (c and d), showing total (i.e., nonimmunoprecipitated) transla- 
tion  products  from total CXF-87 RNA  (finoroantoradiograph). 
Note the identification of the major (basic) variant of polypeptide 
IT as a genuine translation product (d and e). (fund g) Cytoskeletal 
proteins of HT-29 cells (f, silver staining; g, fluoroautoradiograph 
of [35S]methionine-labeled  proteins). (h) Translation products im- 
tected in some preparations but not in all. Patterns of tryptic 
peptide maps were essentially identical for these three iso- 
electric variants and lacked similarity with those of any of 
the established IF proteins such as CKs 8, 18, and 19, vimen- 
tin and desmin (not shown; see references 64-66, 82). This 
suggested that polypeptide IT was not merely a proteolytic 
product of other cytoskeletal proteins such as CK 8 which 
is  known  to  be  particularly  vulnerable to  such  degrada- 
tions (81). 
Protein IT was present at the highest amountsrelative to 
other eytoskeletat proteins in preparations of  villi from small 
intestine, notably duodenum and jejunum, where it occurred 
in amounts only slightly lower than those of CK 8 and ex- 
ceeding those of both CKs 18 and  19 (Fig.  1, a  and b). Its 
proportion was lower in preparations from mucosa of the il- 
eum and the colon which, in turn, contained more CK 19 
(not shown; e.g., Fig. 2 b of reference 65). Polypeptide IT 
was also identified among the total duodenal mucosa pro- 
teins that had been instantly denatured by immersion of fro- 
zen sections into boiling SDS-PAGE sample buffer (data not 
shown). 
Protein IT was also a major cytoskeletal protein in human 
colonic adenocarcinomas grown in nude mice (Fig.  1 c). 
When total RNA or poly-A+-RNA from such tumors was 
translated in vitro and the resulting products immunoprecipi- 
tated by antisera against protein IT (see below) and analyzed 
by two-dimensional gel electrophoresis, the polypeptide IT 
spot was clearly identified (Fig. 1, c and d). This showed that 
protein IT is a  genuine polypeptide encoded by a  distinct 
mRNA.  Remarkably, however, the amount of mRNA  en- 
coding polypeptide IT was lower than those of mRNAs en- 
coding CKsS,  18, and  19, as it appeared only as a minor 
translation product before enrichment by immuuoprecipita- 
tion (Fig.  1 e). 
Protein  IT  was  also  consistently  found in~cytoskeletal 
preparations from cultured human colon carcinoma cells of 
cell line HT-29 (Fig.  1 f; see also Fig. 2 k of reference 65). 
In such cells, however, an additional, more basic isoelectric 
variant (pH ,-6.25) was often seen (of. Fig. 1 h). When HT- 
29 cells were incubated with medium containing [3~S]me- 
thionine, polypeptide IT was significantly labeled but to a 
lesser extent than CKs 8  and  18 (e.g.,  Fig.  1 g). In vitro 
translation of  mRNA from HT-29 cells also showed the pres- 
ence of mRNA encoding polypeptide IT among the HT-29 
mRNAs  (Fig.  1 h). 
A  cytoskeletal protein with  similar preparative and  gel 
electrophoretic properties as human protein IT, which also 
munoprecipitated after in vitro translation of total RNA from HT- 
29 cells (fluoroautoradiograph). Note the presence of  an additional, 
more basic variant of  IT protein. (i-l) Electrophoresis of  cytoskele- 
tal proteins of rat small intestinal mucosa and corresponding immu- 
noblot experiments. Total blot-transferred proteins are shown in i 
(Ponceau S red staining) and I (India ink staining subsequent to 
immunoblot). The corresponding immunoblots, using guinea pig 
antibodies against human IT protein and visualization of  bound sec- 
ondary antibodies by immunoperoxidase staining ~j and k corres- 
ponding to i and l, respectively) reveal a single positive protein 
(F/R), which is slightly more acidic than the rat orthologue to CK 
18 (CK 18R). 
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human protein IT by immuno- 
blotting (a-k),  "blot-binding" 
assays (l and m),  and native 
electrophoresis (n-p).  (a and 
b) Two-dimensional gel elec- 
trophoresis of duodenal eyto- 
skeletal proteins (a, Coomassie 
blue staining) and correspond- 
ing  immunoblot after  reac- 
tion with guinea pig antibodies 
against bovine snout CKs that 
had been  affinity purified on 
CKs 14-17 (b, autoradiograph 
after secondary ~I-protein A 
binding). Note that these type I 
CK-specific antibodies  react 
both with CK 19 and protein 
IT (/7). (c-f) Immunoblot re- 
suits of cytoskeletal proteins 
from duodenal mucosa (c and d) and hair follicle root sheaths (e and f) after separation by two-dimensional gel electrophoresis, transfer 
to nitrocellulose, and reaction with IFA antibody (c and e, immunoblot reactions, peroxidase staining; d and f, subsequent India ink stain- 
ing). Note that this antibody is negative not only with protein IT (arrow in c; d) but also with CKs 16 and 17 (arrow in e; f), whereas 
CKs 8,  18, and 19 (c) and CKs 5, 6, and 14 (e) are positive. (g-k) Dot-blot assays (/1 and j, Ponceau S staining; i and k, corresponding 
immunoreaction, peroxidase staining) with antibodies lu-5 (i) and Ks 18.174 (k), showing the positive reaction of electrophoretically 
purified protein IT (purity is demonstrated by gel electrophoresis in g; P, 3-phosphoglycerokinase from yeast, added for reference) with 
CK antibody lu-5 (dots 2 and 2' in h and i; positive conti'ol: dots I and r, purified CK 19; negative controls: dots 3 and 3', purified vimentin, 
and dots 4 and 4', purified desmin; see reference 26). In contrast, the CK 18-antibody K, 18.174 is negative with protein IT (dots 2 and 
2' inj and k; positive control: dots 1 and 1', showing total cytoskeletal proteins from MCF-7 cells). (l and m) Nitrocellulose blot-binding 
assay, using 125I-labeled CK 8 (A) from rat liver. The blot of SDS-PAGE-separated cytoskeletal proteins from human small intestinal 
mucosa (lane 1 ) and MCF-7 cells (lane 2) is shown by India ink staining in l; m shows the corresponding autoradiograph after incubation 
with labeled CK A in 4 M urea-containing buffer (40). The bars denote, from top to bottom, CKs 8, 18, and 19; the arrowheads designate 
protein IT. Note the positive reaction not only of CKs 18 and 19 but also of protein IT (m, wvowhead), indicating heterotypic complex 
formation. (n and o) Electrophoresis under nondissociating conditions in the presence of 4 M urea (E; from left to right), followed by 
SDS-PAGE (SDS) in the second dimension, of purified CK 8 (n), protein IT (o), and the complex formed by an approximately equimolar 
mixture of CK 8 and protein IT (p; silver staining). Note that in the mixture both proteins migrate in E to an identical position (/arge 
arrow inp), corresponding to a slowly migrating heterotypic complex, as compared to the faster migration of  each of  the individual polypep- 
tides (small arrows in n and o). Minor polypeptide spots probably represent degradation products of CK 8 (n, arrowheads)  or protein 
IT (o, bottom spots) or both (p). The hatched arrow in o designates a trace of contamination of CK 8 included in a complex with protein 
IT; the small vertical arrow inp points to some protein IT not included in the complex. B, BSA added for reference. For further designations, 
see Fig.  1. 
reacted with the antibodies specific for the human protein 
(see below, Fig. 4, d and e), was found in intestinal mucosa 
of the rat (Fig. 1, i-t). Relative to the rat Ortholog of human 
CK 18 (18R in Fig.  1,  i-l;  component D; see reference 19, 
20, 22), the IT protein ortholog (ITR) was more acidic (pH 
,,05.35  in the system used) and migrated slightly faster in 
SDS-PAGE, corresponding to Mr "o46,000 (Fig.  1,  i-l). 
A series of immunoblotting experiments was performed in 
order to assess the relationship of protein IT to CKs. Only 
one guinea pig antiserum raised against the type I CKs VIa,b 
from bovine muzzle epidermis,  which in  immunoblotting 
reacted with most human type I CKs (including CKs 10, 11, 
13, 14, 16, 17, and 19, but not 18) but with none of the type 
H CKs (including CKs 4-8) showed a significant and strong 
reaction with protein IT (see also 64). After affinity purifica- 
tion  on nitrocellulose paper  strips  containing  CKs  14-17 
from human  hair follicles, the remaining antibodies were 
still positive for polypeptide IT in immuttoblotting experi- 
ments using duodenal cytoskeletal proteins (Fig. 2, a and b). 
While this result suggested, but did not prove, a true cross- 
reactivity (i.e. very similar epitope[s]) between type I CKs 
and polypeptide IT, a large series of established monoclonal 
antibodies against various CKs of type I and type !1 did not 
react with protein IT. These negative antibodies included not 
only several broad spectrum CK antibodies (Ko 8.13, K,pan 
1-8.136, KL 1, LP 34, PKK 1) but also the monoclonai anti- 
bodies AE 1 and KA 4, both known to react with several type 
I CKs, and monospecific antibodies to CKs 8 (K, 8A.42 and 
CAM 5.2), 18 (e.g., CK-1, CK-2, CK-3, CK-4, RGE 53, Ks 
18.174,  and K, 18.27.IV),  19 (Ks 19.1, Ks 19.2.105,  BA 16, 
and BA 17), 13 (1C7, 2D7; see reference 88), and to an epi- 
tope common to 13,  14, and 16 (Ks 13.1; see reference 67). 
Monoclonal antibody IFA (72) whose epitope is located at 
the COOH-terminal end of the or-helical  rod domain that is 
common to most IF proteins (34, 60), strongly reacted, in 
immunoblots of duodenal cytoskeletai proteins, with CKs 8, 
18, and 19 but was negative with protein IT (Fig. 2, c and 
d). One should note, however, that certain established type 
I CKs such as components 16 and 17 also did not react with 
this antibody under our experimental conditions (Fig. 2, e 
and ~  see also reference 8). 
The  widely  used  monoclonai  antibody  lu-5  has  been 
shown to react, in dot-blot assays, with a wide range of type 
I  and  type II  CKs  but  not  with  other  IF  proteins  (26), 
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heterotypic CK complexes and their melting behavior, which 
implies two-dimensional gel electrophoresis at different urea 
concentrations  and  is  based  on differences of isoelectric 
points between the individual CKs (25), was not feasible in 
the case of polypeptide IT as its isoelectric point at 9.5 M 
urea is very similar to that of its putative complex partner, 
CK 8 (Fig.  1, a-h).  Alternatively, we therefore performed 
"native complex electrophoresis" of a  near-stoichiometric 
Figure 3. Electron micrographs showing  typical IFs (arrows)  recon- 
stituted from an equimolar mixture of purified human CK 8 and 
protein IT (a, negative staining). Note also some loosely arranged 
protofilaments in the background (arrowheads). In control experi- 
ments with only CK 8 (b) or protein IT (c) coarse rodlike aggregates 
are seen but no IFs. Bars, 0.1 tzm. 
whereas it was negative in immunoblots of SDS-PAGE-sepa- 
rated CKs.  Therefore, we purified protein IT by two-step 
preparative gel electrophoresis, to avoid any contamination 
with CKs 8 or 18 (for purity, see Fig. 2 g), and applied the 
protein partially refolded in buffer containing 4  M  urea to 
the same dot-blot assay. As shown in Fig. 2, h and i, antibody 
lu-5 reacts with protein IT just like with other CKs, but not 
with vimentin and desmin (see reference 26).  In a control 
dot-blot assay  with  antibody Ks  18.174,  cytoskeletal pro- 
teins containing CK 18 were strongly positive whereas pro- 
tein IT was negative (Fig. 2, j and k), which also showed that 
no contaminating CK 18 was present in our IT protein prepa- 
rations. 
Molecular Assembly Studies 
Hatzfeld et al. (40) have established an in vitro binding assay 
which allows to identify and distinguish type I and type II 
CKs by the heterotypic binding of a radiolabeled solubilized 
CK to a blot-immobilized CK (for examples also see refer- 
ences 59, 61). When gel electrophoretically separated, cyto- 
skeletal proteins from small intestinal mucosa were trans- 
ferred to nitrocellulose paper (Fig. 2 l) and incubated with 
purified,  ~25I-labeled rat CK 8  (A;  see references 19,  20, 
40), positive reactions indicating specific binding were ob- 
served not only for CKs 18 and 19, as expected, but also for 
polypeptide IT (Fig. 2 m). Although in such tests the reactiv- 
ity of protein IT was somewhat weaker than those of CKs 18 
and 19, it was clearly specific as all the other proteins pres- 
ent,  including CK 8  (Fig.  2  l),  were completely negative 
(Fig. 2 m). Corresponding results were obtained in similar 
assays, using two-dimensional gel electrophoresis (data not 
shown). In the complementary assay with radioiodinated CK 
18, only CK 8 was reactive but not the other proteins, includ- 
ing the type I CKs 18 and 19 and protein IT (data not shown). 
Thus, in this assay,  protein IT behaved like a type I  CK. 
We then tested whether polypeptide IT was able to form 
correct heterotypic complexes with type II CKs in solution. 
Figure 4. Gel electrophoresis of  polypeptide fragments produced by 
chymotryptic digestion of human duodenal cytoskeletal material (a 
and  f), combined with immunoblotting using guinea pig antibodies 
against protein IT (b and g; antibody characterization: d and e) and 
a murine CK 19 antibody (c). (a) SDS-PAGE  (15 % acrylamide; sil- 
ver staining) of  proteins of  intact cytoskeletal material from MCF-7 
cells (lane 1; bars, from top to bottom, denote CKs 8, 18, and 19; 
the latter appears underrepresented in the photograph due to its yel- 
low color) and from duodenal mucosa (lane 2; crude cytoskeletal 
preparation; arrowhead designates protein IT; small white dots de- 
note the position of BSA), in comparison with chymotryptic diges- 
tion products derived from duodenal mucosal cytoskeletons (lane 
3).  (b and c) Corresponding immunoblots (peroxidase staining) 
using antibodies against protein IT (b) and, for comparison, anti- 
body Ks 19.2.105 against CK 19 (c). Note the specific reaction of 
the former antibodies only with protein IT (b, lane 2', arrowhead) 
and primarily with one major chymotryptic fragment (dot in b, lane 
3';  corresponding to the dot in a,  lane  3; Mr ~38,000)  that is 
slightly larger than the chymotryptic rod fragment of  CK 19 (c, lane 
3"). (d-g) Two-dimensional gel electrophoresis of HT-29 cytoskel- 
etal proteins (d, Ponceau S red staining after transfer to nitrocellu- 
lose) and of chymotryptic digestion products from duodenal mu- 
cosal cytoskeletons (f, showing several spots of polypeptides more 
acidic than actin; Coomassie blue staining) and corresponding im- 
munoblots (peroxidase staining) using antibodies against protein IT 
(e and g). Note that these antibodies specifically react with protein 
IT (e), a minor degradation product derived therefrom (arrowheads 
in e and d) and one major distinct Mr ,~38,000 chymotryptic frag- 
ment (fand g, arrowheads). For further designations see legends 
to Figs. 1 and 2. 
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Figure 5. Partial amino acid sequences of human protein IT frag- 
ments obtained by digestion with Staphylococcus V8 protease and 
separation by reverse-phase HPLC:  IT-A, IT-B, fragments with 
high homology to coil Ia of type I CKs; IT-C and IT-D, fragments 
with high homology to coil II. These sequences are compared with 
the corresponding sequences of various human type I CKs: CK 14 
(60), CK 16 (77, 80), CK 15 (57), CK 19 (3), CK 13 (53, 62), CK 
10 (78, 93; see reference 51), CK 18 (56). Residues identical in 
polypeptide IT and at least one of the other CKs are in bold letters. 
Dots denote omissions introduced to optimize alignment. 
mixture of CK 8 and protein IT at 4 M urea, i.e., under non- 
dissociating conditions. CK 8 and protein IT, purified first 
by DEAE cellulose chromatography and then by reverse- 
phase  HPLC,  when applied  separately,  migrated  slightly 
slower than the reference protein BSA (B, Fig. 2, n and o), 
suggesting that they were present as monomers or homodi- 
mers under these conditions. However, when CK 8 and pro- 
tein IT were applied in a near stoichiometric mixture, both 
polypeptides migrated much more slowly in the first dimen- 
sion, with a retardation compatible with the interpretation 
of a heterotetrameric complex (Fig. 2 p). When a mixture 
of CKs 8 and 18 was applied in a parallel experiment, they 
migrated  together in  first-dimension  electrophoresis,  and 
similarly to the mixture of CK 8 and protein IT (not shown). 
Since CKs 8 and 18 have been shown, by independent meth- 
ods, to be present as a heterotetramer complex in 4 M urea 
(40, 73-75), the present data suggest that the complex of CK 
8 and protein IT is also a heterotetramer. When similar ex- 
periments were performed with native cytoskeletal proteins 
from duodenal mucosa (i.e., total cytoskeletal material solu- 
bilized in 9.5 M urea-containing buffer and dialyzed against 
4 M  urea), CKs 8,  18,  19 and protein IT all migrated to a 
position corresponding to that of the authentic complex of 
CKs 8 and 18. 
To examine whether mixtures of CK 8 and protein IT can 
also assemble into IFs, in vitro re,  constitution experiments 
were performed using the same protein preparations as for 
native gel electrophoresis (Fig. 2, n and o), followed by dial- 
ysis against a 10 mM Tris-HC1 buffer, and electron micros- 
copy. In such tests, not only arrays of 2-5 nm protofilaments 
were observed but also many long •10  nm filaments with 
typical IF appearance (Fig. 3 a; see reference 39). Only short 
rod-like or irregular structures but practically no filaments 
were observed in control experiments using CK 8 or protein 
IT alone (Fig. 3, b and c). 
A typical feature of  IF proteins, when integrated in subunit 
complexes or IFs, is the existence of a relatively protease- 
resistant core fragment of approximately Mr 38,000, largely 
corresponding to the a-helical rod domain forming coiled 
coils (see references 9, 35, 40, 83, 91). Therefore, we exam- 
ined whether fragments produced from native CK IFs from 
intestinal mucosa by limited chymotryptic digestion also in- 
cluded a fragment derived from protein IT. When cytoskele- 
tal material from duodenal villi (Fig.  4  a,  lane 2;  lane 1 
shows as a control MCF-7 cell cytoskeletons) was subjected 
to  limited chymotryptic cleavage,  several  new  bands  ap- 
peared in the Mr range of 35,000-40,000 (Fig. 4 a, lane 3). 
These polypeptides were characterized in immunoblot ex- 
periments using guinea pig antibodies specific for protein IT 
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Figure 6.  Schematic representation  of the  catalogue  of human 
cytokeratins, supplemented by CK 20 (protein IT). The epithelial 
(CK I-CK 20) and trichocytic (Ha 1-4, Hax, Hb 1-4, Hbx; see refer- 
ence 41) CK polypeptides are shown as closed circles and squares, 
arranged according to their migration in two-dimensional gel elec- 
trophoresis: abscissa, isoelectric pH in the presence of  9.5 M urea; 
ordinate, Mr value in SDS-PAGE. Open circles indicate the exis- 
tence  of a  second  kind  of CK  2  (one  typically  expressed  in 
epidermis, the other in gingiva and hard palate epithelium) and pos- 
sibly also CK 6 (for references see 31). Note that CK 20 is the most 
basic type I cytokeratin. 
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reactivity with CKs 8, 18, and 19 see Fig. 4, a and b, lanes 
1, 2,/', 2', d, and e). These antibodies did also not react, in 
immunoblotting, with any other CK or cytoskeletal protein 
present in a  variety of human cells and tissues (including 
epidermis, hair follicle root sheaths, MCF-7 and HeLa cells; 
not shown) and recognized only protein IT, not only among 
the (intact) cytoskeletal proteins from duodenum (Fig. 4, a 
and b, lanes 2, and 2') but also among total cellular proteins 
of colonic carcinomas (not shown). 
In the chymotryptic digests, these antibodies specifically 
reacted with one major band,  corresponding to  a  Mr of 
,,o 38,000 (Fig. 4, a  and b, lanes 3, and 3', solid circles). A 
monoclonal antibody against CK 19 used for comparison 
recognized its antigen among the intact proteins (Fig. 4, a 
and c, lanes 1, 2, 1", and 2") as well as among the products 
of chymotryptic  digestion of IFs (Fig. 4, a and c, lanes 3, and 
3"). Correspondingly, monoclonal antibodies against CK 18 
recognized, among the chymotryptic digestion products, a 
polypeptide doublet slightly larger than the fragment from 
polypeptide IT (Mr ,~,40,000; not shown) and antibody I~pan 
1-8.136 reacted with intact CK 8 and, in the digest, with sev- 
eral bands in the Mr ranges of 35,000-38,000  and 20,000- 
23,000 (not shown; see reference 40). When the chymotryp- 
tic digestion products were separated by two-dimensional gel 
electrophoresis and immunoblotted, again one major poly- 
peptide spot was recognized by the protein IT antibodies 
(Fig. 4, land g). Tryptic peptide map comparison of this im- 
munoreactive Mr '~38,000 product of the chymotryptic re- 
action with the intact polypeptide of Mr '~46,000  showed 
very similar patterns,  supporting our interpretation of the 
derivation of this fragment from IT. 
Partial Amino Acid Sequences of  Peptide Fragments 
For determinations of amino acid sequences,  cytoskeletal 
proteins of duodenal mucosa were separated by SDS-PAGE. 
The band containing polypeptide IT was excised from the 
gels and the protein electroeluted and subjected to digestion 
with staphylococcal V8  protease.  Peptide fragments were 
separated by microbore reverse phase HPLC and sequenced 
by Edman degradation. 
Amino acid sequence comparison (Fig. 5) showed that the 
fragment IT-A had a high homology to the beginning of coil 
Ia of type I CKs. In a comparison with CKs 10, 13, 14, 15, 
16, 18, and 19, a total of 13 out of 16 IT-A residues were iden- 
tical to those in the majority of the type I CKs, whereas two 
residues were different in protein IT from all the other CKs. 
Fragment IT-B could be aligned to a region close to the end 
of coil Ia, but here the differences from the other type I CKs 
were much greater:  out of the 27  residues determined, 9 
were different in protein IT and they did not occur in any of 
the type I CKs. 
The fragments IT-C and IT-D were highly homologous to 
two coil II regions of the type I CK subfamily. Also in these 
two fragments, several residues were shared with all the type 
I CKs but several unique amino acid exchanges distinguished 
polypeptide IT from all the type I CKs. In fragment IT-C 
these are: leucine (position 8), asparagine (position 9), gly- 
cine (position 11), and valine (position 12). In fragment IT-D 
there are four such differences: lysine (positions 2 and 7), 
valine (position 10), and threonine (position 13), and in posi- 
tion 14 there is an additional glutamine in protein IT (Fig. 5). 
These sequence homologies provide direct proof that pro- 
tein IT belongs to the type I subfamily of CKs, and it is there- 
fore included in the catalogue of human CKs as CK 20, espe- 
cially as it can obviously complement and replace CKs 18 
and 19 in intestinal epithelia. Fig. 6 represents an accord- 
ingly completed catalogue of human CKs on the basis of 
analyses by two-dimensional gel electrophoresis. 
Immunolocalization of Cytokeratin 20 in Cells 
and Hssues 
The guinea pig antibodies specific for CK 20 (protein IT) al- 
lowed its immunolocalization  in human cells. In all cases, the 
immunocytochemical results were in agreement with our 
biochemical data concerning the presence of CK 20 (for the 
urothelium, see also 67). However, understandably, CK 20 
was not detected biochemically in those tissues in which only 
few CK 20-positive cells were seen immunocytochemically. 
Immunofluorescence microscopy on cell cultures of the 
human  colon  carcinoma-derived  line  HT-29  showed  ex- 
tended cytoplasmic staining, sometimes with recognizable 
fibrillar pattern (Fig. 7 a), which varied considerably in in- 
tensity even among adjacent ceils. In cells of the line LoVo, 
also derived from a human colonic carcinoma, a very dis- 
tinct fibrillar immunofluorescence was seen in many cells, 
including mitotic ones (Fig. 7,  b and c):  in a  typical, ex- 
ponentially growing culture, ~20% of  the cells were positive 
and these tended to be enriched in the periphery of the cell 
colonies (Fig. 7, b and c). In some cells, the immunofluores- 
cence appeared, partly or totally, in the form of small "dots" 
(Fig.  7,  d  and e),  reminiscent of the  spheroidal CK ag- 
gregates described in mitotic cells of various origins, colon 
carcinomas included (7, 23, 32, 44, 55), but also in inter- 
phase cells of some lower vertebrates (see reference 47). 
Variable subpopulations of cells immunostained with CK 20 
antibodies were also consistently observed in the colorectal 
carcinoma lines DLD-1,  SW 1116, and Caco-2, whereas in 
our cell cultures of line COLt 320 DM positive cells were 
only occasionally encountered.  Likewise, a  considerable 
proportion of CK 20-positive cells were seen in cell cultures 
of the bladder carcinoma line RT-4 and in a small proportion 
of positive cells occurred in the hepatoceUular carcinoma 
line Hep-G2. MCF-7 mammary carcinoma cells as well as 
a number of other human nonlntestinal cells examined were 
completely negative with the CK 20 antibodies. In immuno- 
electron microscopy of HT-29 cells, these antibodies deco- 
rated typical IF structures (not shown). 
A  large spectrum of different normal human tissues, as 
well as some rat tissues, were examined for the presence of 
CK 20, using immunofluorescence and immunoperoxidase 
microscopy. In all positive ceils, the staining was confined 
to  the  cytoplasm and  often  fibrillar  structures  could  be 
resolved (Fig. 8).  Results are presented in Fig. 8. 
In human small intestine (Fig. 8 a), strong and uniform 
staining for CK 20 was detected in both major kinds of epi- 
thelial cells, enterocytes and goblet cells, in regions lining 
the villi. In the crypts, the staining appeared more patchy 
(see also reference 63). Some small and slender, but lumen- 
reaching "undifferentiated" cells at the bases of the crypts 
were also positive whereas adjacent cells were negative (Fig. 
8  a,  inset).  The colonic mucosa exhibited an essentially 
similar pattern as the small intestine, with a rather uniform 
staining of the surface epithelium and the necks of the crypts 
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the bodies and the bases of the crypts (Fig. 8 b). 
In rat colonic mucosa, again the most differentiated sur- 
face epithelium was uniformly positive, whereas the entero- 
cytes of deeper crypts were only weakly immunostained or 
not at all (Fig. 8 c). In these crypts, however,  we observed 
scattered, single, dendritic ceils, often situated between the 
enterocytes and the basal lamina, which were conspicuously 
strongly positive for CK 20 (Fig. 8 c, arrow) and might be 
endocrine in nature. 
Zonal differences were also apparent in human stomach 
mucosa  (Fig.  8,  d  and. e).  The  foveolar epithelium was 
strongly and uniformly positive for CK 20 (Fig. 8 d). The 
specific glands of the corpus mucosa (not shown) as well as 
most mucous cells of the pyloric glands (Fig. 8 e, bottom) 
remained unstained. However,  a variable number of single 
-CK 20-positive epithelial cells was observed in the upper 
zone of the pyloric glands (Fig. 8 e). A considerable propor- 
tion of  these single CK 20-positive ceils represents endocrine 
cells as shown by double immunolabeling with an antibody 
against chromogranin (Moll, R., and W. W. Franke, unpub- 
lished data). 
Nor/'nal human liver and pancreas were completely nega- 
tive. In contrast, in rat liver and pancreas the epithelium of 
the biliary and pancreatic ducts was strongly irnmunostained 
whereas the hepatocytes and the pancreatic acinar and islet 
cells were negative (not shown). The significance of these 
species differences remains unclear. In human gall bladder 
mucosa, only very few epithelial cells were positive. Human 
lung was almost entirely negative for CK 20, with the excep- 
tion of extremely scarce CK 20-positive columnar cells pres- 
ent in some samples of bronchial epithelium (not shown). In 
human thymus, a  small proportion of the reticulum cells, 
mostly in the thymic medulla, was stained for CK 20. 
In human and rat urothelium, CK 20 immunostaining was 
found mostly in  superficial  ("umbrella") cells,  exhibiting 
marked cell heterogeneity of reaction (Fig. 8 f). In human 
prostate gland, a very small subpopulation of glandular cells 
was positive (not shown). In fetal and adult human skin, the 
only cells positively stained for CK 20 were the Merkel cells 
(Fig. 8 g; see reference 64). All other epithelia examined, 
including the epithelia of human salivary glands (Fig. 8 h), 
mammary gland, human and rat kidney parenchyme, and 
human female genital tract were negative for CK 20, as were 
all nonepithelial tissues. 
Synthesis of CK 20  was also observed  in colon carci- 
nomas, primary tumors as well as metastases (a peritoneal 
metastasis is shown in Fig. 8 i; 63) and other carcinomas 
which arise from CK 20-producing epithelia (63, 64, 67). A 
detailed study of the distribution of CK 20 in human tumors 
and possible diagnostic implications will be presented else- 
where .(Moll, R., and W. W. Franke, manuscript in prepa- 
ration). 
A CK 20-related polypeptide was also found in the duo- 
Figure 7. Immunofluorescence  microscopy  of  cultured cell lines de- 
rived from human colonic carcinomas, using guinea pig antibodies 
specific for CK 20 (protein IT). (a) HT-29 cells, showing a fnely 
fibrillar reaction. Note that some cells in this colony are negative 
(one is denoted by an arrow). (b-e) LoVo cells (b and d,  im- 
munofluorescence; c and e, corresponding phase-contrast micro- 
graphs), exhibiting a prominent CK-type fibrillar network (b) also 
in a mitotic cell (arrows in b and c), whereas in some cells the CK 
20 label appears in small dots (d). Again, note the presence of  nega- 
tive cells next to positive ones (cf. b and d with c and e). In contrast, 
antibody Ks 18.174 against CK 18 decorated all cells present in 
this culture (not shown). Bars, 20/zm. 
Moll et al. Identification of Cytokeratin 20  575 Figure 8. Immunocytochemicai detection of CK 20 (protein IT) in various human (a, b, and d-i) and rat (c) tissues, using specific guinea 
pig antibodies in immunoperoxidase (a, b, and d-i) and immunofluorescence (c, inset in b) microscopy on acetone-fixed cryostat sections. 
(a) Duodenal mucosa, showing uniform staining of epithelial intestinal cells along the villi (top), which is particularly strong in the apical 
zones of  enterocytes, and heterogeneous staining in the crypts (bottom and inset). The subpopulation of  positive crypt cells includes slender 
undifferentiated (large arrowheads)  and goblet cells (arrows).  MM, muscularis mucosae. Staining of some infiltrating leukocytes in the 
lamina propria is due to the presence of endogenous peroxidase (small arrowheads,  a and b). (b) In colonic mucosa, the surface epithelium 
is uniformly positive for CK 20 while the crypt epithelium shows lesser, heterogeneous staining. Note the conspicuous basketlike staining 
pattern of the goblet cells (inset) that is similar to the patterns previously described for reactions with antibodies to other CKs (e.g.,  18, 
22, 24). (c) Rat colon also shows predominant staining of the surface epithelium. Note one strongly stained dendritic cell within the crypt 
epithelium (arrow). (d and e) Human stomach mucosa (pyloric region) is characterized by extended positive stainin~ of  the foveolar epithe- 
lium (d), as well as staining of scattered epithelial cells in the upper glandular zone (e). (f) In the urothelium (ureter), a proportion of 
umbrella cells is n~oderately  or strongly decorated by the CK 20 antibodies. Note weaker staining of a few intermediate cells of the uro- 
thelium (arrow). (g) Specific decoration of dendritic Merkel cells in human fetal (14 wk) plantar epidermis in parabasai position. (h) Nega- 
tive reaction of human submandibular gland. (i) Moderately to poorly differentiated adenocarcinoma of the colon (abdominal wall metas- 
tasis) revealing heterogeneous, mosaic-like staining of tumor cells for CK 20. L, lumen. Bars: 50/~m;  insets, 20 ~m. 
denal  epithelium  of the  pig,  by  both  immunoblotting  of 
cytoskeletal proteins and immunofluorescenee microscopy 
(not shown). Interestingly, in the mouse, only small intesti- 
nal mucosa showed some scarce and scattered epithelial cells 
reactive with the CK 20 antibodies, which were mainly lo- 
cated in the crypts, whereas other murine tissues (liver, uri- 
nary bladder, endometrium, and tongue) were completely 
negative for CK 20 (not shown). 
Discussion 
Our results  show that a  polypeptide of Mr  ~46,000  from 
human intestinal mucosa, which is enriched in IF cytoskele- 
tons together with CKs 8, 18, and 19 and which we have pre- 
viously designated protein IT (65), is a genuine translation 
product and a  member of the type I  CK subfamily.  The 
identification of this polypeptide as a CK has been extraor- 
dinarily difficult as  it did not cross-react with any of the 
numerous  available monoclonal CK antibodies,  including 
the monoclonal IFA antibody (72) that is widely used as a 
general IF probe. However, we are also aware of the fact that 
this antibody, which recognizes a rod epitope near the end 
of coil II common to many IF proteins (see references 34, 
59), does react well with all type IICKs but not, or only very 
weakly, with several type I CKs, including human CKs 16 
and  17  (this study;  see also references 5,  8).  Our partial 
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these reactions. On the one hand, the obvious homologies to 
other type I CKs identify this polypeptide as a member of 
this IF protein subfamily; on the other hand, CK 20 differs 
in a remarkably high number of amino acid positions from 
all the other sequenced type I CKs. This should be expected 
to result in the inactivation of a number of epitopes specific 
for, or common to, other members of this family. 
While CK 20 differs from other type I CKs by its excep- 
tionally high isoelectric point (see, however, the broad range 
of isoelectric values of both type I and type IICKs in fish; 
61) it functions as a typical type I CK in several ways: (a) 
It forms heterotypic complexes with type H CKs; (b) it inte- 
grates with CK 8 into IF rod structures in a similar way as 
CKs 18 and 19 do; (c) it is part of the general cytoplasmic 
IF fibril system typical for desmosome-connected epithelial 
cells; and (d) it can show similar transient changes of organi- 
zation from IF to spheroidal aggregate structure, as reported 
for other CKs (see references 7, 23, 32, 44, 55). Moreover, 
it is apparently conserved during mammalian evolution as an 
equivalent, probably orthologous polypeptide occurs in sev- 
erai other species. 
In contrast to the other simple epithelial CKs 8,  18, and 
sometimes  also  19  which  may  be  expressed  in  certain 
nonepithelial cells (for references see 3,  15, 27, 47), CK 20 
seems to be strictly epithelium specific. Both our biochemi- 
cal analyses and the more sensitive immunocytochemical 
studies have revealed a unique and unusually restricted tissue 
distribution spectrum of CK 20 that seems to occur only in 
certain cells of some simple and a few "complex" epithelia. 
A limited tissue distribution restricted to a subset of simple 
glandular epithelia and to transitional epithelium has been 
described for a  putative CK-IF-associated epitope recog- 
nized by a certain monoclonal antibody (69) but this antigen 
is clearly different from CK 20. The immunocytochemical 
observations made with CK 20 antibodies probably reflect 
true synthesis because of the correlation between immuno- 
staining intensities and the protein amounts found on gel 
electrophoresis (for the urothelium, see also 67). 
CK 20 is usually coexpressed with simple epithelial CKs, 
most commonly with CKs 8,  18, and 19, as in foveolar epi- 
thelium of the stomach mucosa, in intestinal epithelium, in 
colon carcinomas and cell lines derived therefrom, and in 
Merkel cells and neuroendocrine tumors of the skin (for the 
latter see also 42, 64). In these cell types, CK 20 is obviously 
present in heterotypic complexes with the type II CK 8 in 
which it seems to "compete" with the other type I CKs 18 
and 19. Correspondingly, CK 20 is found in large amounts 
in tissues and cells in which these last are relatively low, and 
vice versa. In extreme cases, certain cells can produce CKs 
8 and 20 as their by far predominant CK "pair" (examples 
include some specimens of duodenal epithelial cells and 
Merkel cell tumors; this study and reference 64).  In these 
cells, the CK IFs present must be constituted almost entirely 
by heterotetrameric complexes of CKs 8 and 20. Other CK 
20-expressing  epithelia such as the urothelium (umbrella 
cells) contain, in addition to CK 8, the type IICK 7, and here 
it is clear that the cells expressing CK 20 also synthesize CKs 
7,  8,  18, and 19 since all these can be localized uniformly 
in the same umbrella cells (see reference 67). The reticulum 
cells of the thymus represent the only, partly and potentially, 
CK 20-expressing cell type that is capable of differentiation 
to stratified epithelial features, including several "stratifica- 
tion-related" CKs (66) and the ability to form the epidermoid 
Hassall bodies. It remains to be studied by double-label im- 
munofluorescence microscopy whether some of the sparse 
thymic reticulum cells producing  CK 20  also  synthesize 
stratification-related CKs. 
In  both  human  and  rat  tissues,  most  of the  CK  20- 
containing cells are simple epithelial cells with a polar orga- 
nization,  including the  umbrella  cells of the urothelium. 
Clearly, in both major types of intestinal adiuminal cells CK 
20  is also enriched,  together with the other CKs,  in the 
tonofilaments of the "subapical skeletal disk" (18, 22; for re- 
view see 68). Some kind of polarity is also seen in Merkel 
cells. The only exception here appears to be represented by 
the thymic reticulum cells.  However,  there is no obvious 
correlation with a specific cellular function of  these polar ep- 
itheliai cells since CK 20 is not only found in diverse secre- 
tory cells, particularly mucus-secreting ones (goblet cells, 
gastric foveolar cells), but also in the absorptive cells of the 
gastrointestinal tract and in protective surface-lining cells 
such as urothelial cells. Moreover, several of these tissues 
such as the mucosa of  the small and large intestine, the stom- 
ach and the urothelium, display histological cell-to-cell bet- 
erogeneity of CK 20 expression with a conspicuous predomi- 
nance of CK 20-rich cells in the luminally most exposed 
regions of the mucosa. Perhaps, CK 20-containing IFs and 
tonofilaments make a special contribution to the mechanical 
stability of these  surface-lining tissues.  In  more  general 
terms, this pattern of occurrence of CK 20 may be inter- 
preted in correlation with the process of terminal differentia- 
tion in intestinal and urothelial cells, comparable with the 
expression of "suprabasal" CKs in stratified squamous epi- 
thelia (for examples see references 28, 31, 46, 83, 85). This 
would explain, for example, why in the intestinal epithelium 
only a few of the undifferentiated cryptal cells (for a recent 
review see 38) but nearly all differentiated enterocytes and 
goblet cells are strongly positive for CK 20. Clearly, how- 
ever, the synthesis of CK 20 is not restricted to postmitotic, 
terminally differentiating cells as it has also been detected in 
cultured cells in mitosis (Fig. 7, b and c) and in carcinomas 
(see also reference 63). 
Obviously, the synthesis of CK 20 can be continued during 
fundamental  changes  of cellular  characteristics  such  as 
malignant transformation, progression,  and metastasis of 
carcinomas, and during in vitro culturing. For example, the 
formation of CK 20-containing IFs is maintained in neuroen- 
docrine  (Merkel  cell)  tumors  (64)  of  the  skin  and  in 
urothelium-derived carcinomas (see reference 67), including 
poorly differentiated grade 3 tumors (thus, at least in this 
kind of tumor the correlation of CK 20 expression with the 
level of differentiation as discussed above does not seem to 
hold). Similarly, CK 20 synthesis is a stable feature in adeno- 
carcinomas of the colon (this study and 63), and in various 
colon carcinoma cell lines such as HT-29 and Caco-2. This 
maintenance of expression makes CK 20  a  valuable cell 
typing marker for tracing certain cell lineages during devel- 
opment and for the differential diagnosis of primary and 
metastatic carcinomas, particularly for tumors of the gastro- 
intestinal tract and the bladder. Hence, immunocytochem- 
istry with CK 20 antibodies, especially in combination with 
antibodies to CKs 19 and 7 (for examples see 4, 6,  10, 67, 
71, 87, 92), opens new possibilities in the differentiation of 
the broad group of simple epithelium-derived carcinomas. It 
will also be interesting to compare the advent of CK 20 in 
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presence in tumors in direct comparison with other intestine- 
type cytoskeletal marker proteins such as villin (for review 
see 58). 
An unexpected and conspicuous feature of the distribution 
of CK 20 is the frequency of cell heterogeneity (i.e., the pro- 
nounced tendency to appear in mosaic-like patterns of posi- 
tive and negative cells), even in tissues in which this protein 
is generally prominent as in the intestinal epithelium. While 
certain IF proteins such as CKs 8 and 18 are characterized 
by their uniform expression throughout  simple epithelia (for 
references see Introduction), "patchy" heterogeneities have 
repeatedly been noted for other CKs (for examples see refer- 
ences 4, 6, 67, 88). The appearance patterns of CK 20-posi- 
tive cells in these tissues as well as in some of the CK 20- 
positive tumors seem to be at random, and the cells positive 
for CK 20 are otherwise morphologically indistinguishable 
from those negative  for this protein.  Of course,  more de- 
tailed and special studies will be needed to decide whether 
the  individual  cells positive  for CK  20 differ positionally 
and/or functionally from the negative cells or whether CK 
20 expression in these tissues is merely due to stochastic 
"leakiness" of expression and without crucial functional im- 
portance, as recently described for the expression of CK 18 
in a subpopulation of cultures of transformed nonepithelial 
cells (49). Hopefully, cloned nucleic acid probes for CK 20, 
which so far have been astonishingly refractory to our eDNA 
cloning attempts,  will help in understanding  the principles 
of the regulation of this unusual  cytoskeletal component. 
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